Cancer Law Weekly
Susan Hasty, Publisher
Table of Contents . . . April 16th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Law Weekly | Other Publications
Advanced Biotherapy, Inc. - U.S. patent issued for treatment of AIDS
Ciphergen Biosystems, Inc. - Diagnostics company renews cancer research collaboration with Johns Hopkins
Medical Discoveries, Inc. - Biopharma company acquires assets of Savetherapeutics A.G.
NeoRx Corporation - Cancer therapeutics development company announces financial results
PRAECIS PHARMACEUTICALS INCORPORATED - U.S. CMS issues coverage determination for Abarelix
Albert Einstein College of Medicine - Human neuroblastoma cell growth inhibited by CAY10404
Albert Einstein College of Medicine, New York - Three-year screening interval okay for HIV+ women negative for HPV
American College of Gastroenterology - For African Americans, screening should begin at 45, not 50
Birmingham Women's Hospital - Radical hysterectomy unnecessary for adequate treatment of early stage disease
Breast Cancer - One in 7 minority U.S. women doesn't know family history of breast cancer
Bristol-Myers Squibb - Adjuvant treatment for node-positive breast cancer approved in Europe
California Air Resources Board - California report conclusively links secondhand smoke, breast cancer
Cambridge Inst. for Medical Research, U.K. - Diagnostic test for range of blood disorders on the horizon
Catalyst Biosciences, Inc. - Biopharmaceutical firm appoints David J. O'Reilly as president
Catholic University of Korea, Seoul - The TK1-2 domain of tissue-type plasminogen activator shuts down tumor growth
Celgene Corp. - Company licenses rights to EntreMed for tubulin inhibitor program
Celgene Corporation - Revlimid exceeds expectations in relapsed, refractory myeloma
Chemokine Therapeutics Corp. - Company reports 67% decrease in metastatic nodules with CTCE-9908
Chinese Academy Med Science, Beijing - HPTTG overexpression regulated by betacatenin/TCF pathway in esophageal cancer
Christie Hospital NHS Trust, Lancs - Antisense agent AEG 35156 targets the X-linked inhibitor of apoptosis protein
Chungbuk National University - Aloe polysaccharides studied, role of size in immunomodulation identified
Colorectal Cancer - Educational initiative targeting women gets underway
Columbia University - Researchers examine rhIL-11 for use in children with solid tumors or lymphomas
Comprehensive Cancer Center E. Marquis, Rennes - Tonsillar metastasis revealed signet-ring cell carcinoma of the rectum
CompuData - Cancer-focused biopharmaceutical company selects business management system
Curtin University of Technology, Perth - Dietary lycopene and other carotenoids may protect against prostate cancer
Dalian Medical University - Hematopoietic cells carrying the ribonuclease inhibitor gene hinder melanoma
Democritus University of Thrace - Researchers provide details of new studies and findings in the area of oncology
Duke University - Sustained response noted in patient with bifrontal glioblastoma multiforme
Endocare, Inc. - Device company raises $15.6 million with private placement of common equity
Favrille, Inc. - Immunotherapy company reports 2004 net loss of $54.2 million
GTx, Inc. - Second SARM shows phase I clinical safety
GammaCan International, Inc. - Phase II trial of cancer drug GCAN 101 to start in Israel
Genentech, Inc. - Avastin plus chemotherapy extends survival in first-line non-squamous NSCLC
German Cancer Research Center, Heidelberg - Newcastle disease virus selects tumor cells for gene delivery
Harvard University - Angiogenin promotes cancer cell proliferation as well as angiogenesis
Hebrew University of Jerusalem - Drugs that challenge Ero1-L alpha may beat hypoxia-generated tumor growth
Helsinki University Hospital - CD4+ and CD8+ lymphocytes monitoring during therapy helps prognostic abilities
Hop St. Louis, Paris - Tumor cell HLA-G gene activation involves cis-acting epigenetic changes
Hopital Europeen Georges Pompidou, Paris - Detection of CK19 mRNA by RT-PCR in MLNS associated with increased recurrence
I-Flow Corporation - Long-term benefit of drug delivery device after breast cancer surgery shown
IDM, SA - Epimmune and immunotherapy company to combine businesses
Inst. for Cancer Research and Treatment, Candiolo - Geographic patterns and pathogenetic implications of IGHV gene usage in leukemia
Institute Biology - Bone involvement is high in advanced medullary thyroid cancer
Institute Curie, Paris - UPAR may identify breast cancer patients with a risk for micrometastasis
Institute for Cancer Research, Surrey - BRAF mutations detected in conjunctival but not uveal melanomas
Institute of Clinical Immunology, Novosibirsk - Production of TGF-beta1 and IFN-gamma linked to regeneration of hematopoiesis
Institute of Oncology, Ljubljana - Minimal risk of macrometastases in the NSLN in breast cancer patients
Institute of Oncology, Ljubljana - Role of preoperative ultrasonography in reducing number of SLN biopsies examined
Introgen Therapeutics, Inc. - Data published on nanoparticle delivery of mda-7 in lung cancer
Istituto Clinico Humanitas, Milan - Lower incidence of intrahepatic recurrences via resection than radiofrequency
Istituto Nazionale Tumori, Milan - Case of gastric tumor of the Carney triad reported
Istituto Nazionale Tumori, Milan - Rare Met proto-oncogene juxtamembrane variations linked to tumorigenesis
Istituto Nazionale Tumori, Milan - Treatment options in hormone-refractory metastatic prostate carcinoma reviewed
Johns Hopkins University - Inhibitory anti-FLT3 antibodies rebuff leukemic induction
Kanazawa University, Ishikawa - Aberrant Pim-3 expression encourages hepatocellular carcinoma proliferation
Kanazawa University, Ishikawa - Dynamic magnetic resonance imaging diagnosed lesions adjacent to pituitary gland
Karolinska Hospital - Current practice of Gleason grading among genitourinary pathologists revealed
Keio University - Novel melanoma antigen FCRL/FREB is immunogenic in multiple melanoma patients
Kochi Medical School - Genes predispose breast cancer patients to tamoxifen-induced fatty liver
Kyoto University - P21(WAF1) examined, physiological effects in fibroblast revealed
Leiden University - Enriched HPV-specific polyclonal T cells may be key to future immunotherapies
M. D. Anderson Cancer Center - Cardiac death after radiation for breast cancer dramatically down, study shows
M.D. Anderson Cancer Center - Deletion of chromosome band 5q linked to refractory myelogenous leukemia
M.D. Anderson Cancer Center - Melanoma differentiation-associated-7 gene transfer eradicates prostate cancer
Massachusetts General Hospital East, Charlestown - Oncolytic herpes simplex virus diminishes mammary tumors in mice
Mayo Clinic - Benefits of lung cancer screening with CT questioned
Medical Academy of Gdansk - Batracyclin derived muramyl dipeptides studied, biological activity reported
Medical College of Ohio Hospital - Clinical trial of monoclonal antibody seeks patients with advanced disease
Medical University of Graz - Mofarotene inhibited melanoma cell motility
Medical University of Vienna - Expression of Ksp-cadherin distinguished renal carcinoma from renal oncocytoma
Memorial Sloan-Kettering Cancer Center, New York - Interlocked dimeric parallel-stranded DNA quadruplex inhibits HIV-1 integrase
Miyazaki University - Neutrophils raise hepatocyte growth factor levels in non-Hodgkin lymphoma
Miyazaki University - TSLC1 overexpression may be a molecular marker for acute-type ATL
Moredun Research Institute - Viruses could deliver HIV, malaria, rabies and cancer vaccines as pills
Nara Medical University - Interferon and perindopril combine to fight angiogenesis and cancer growth
National Cancer Institute - U.S. government funds cancer program to train investigators
National Taiwan University Hospital, Taipei - GRP78 expression correlates with favorable prognosis in neuroblastic tumors
National Tumor Institute, Milan - Reports advance knowledge in oncology research
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
